Skip to content

Evaluation of changes in diurnal variation of intraocular pressure with glaucoma treatment using the Triggerfish.

Evaluation of changes in diurnal variation of intraocular pressure with glaucoma treatment using the Triggerfish. - Evaluation of changes in diurnal variation of intraocular pressure with glaucoma treatment using the Triggerfish.

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000050233
Enrollment
15
Registered
2023-02-04
Start date
2023-01-07
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

glaucoma

Interventions

Measure diurnal variation of intraocular pressure before and 1-3 months after the addition of glaucoma treatment for patients determined to require additional glaucoma treatment.

Sponsors

Tokai University Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Males and females over 20 years of age at the time of registration 2) Patients with glaucoma, preperimetric glaucoma, ocular hypertension, and angle-closure glaucoma who require additional glaucoma treatment 3) Patients who have received sufficient explanation about participation in this research and have obtained written consent of their own free will

Exclusion criteria

Exclusion criteria: 1) Patients who cannot wear contact lenses (patients with contraindicated target diseases as listed in the Triggerfish package insert) 2) Patients who have a history of intraocular surgery within the past 3 months in the test eye 3) Patients who have a history of refractive surgery in the past 4) Patients with a history of glaucoma surgery in the past 5) Patients with keratoconus or other corneal diseases 6) Patients with conjunctivitis or endophthalmitis 7) Other patients who are deemed unsuitable for inclusion in the subject by the physician's judgment

Design outcomes

Primary

MeasureTime frame
The primary endpoint is the absolute difference between the highest and lowest contactlens sensor values (mVeq), as measured by the triggerfish before and 1-3 month after the addition of glaucoma treatment.

Countries

Japan

Contacts

Public ContactTakashi Matsushima

Tokai University School of Medicine Department of Ophthalmology

313550@cc.u-tokai.ac.jp0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026